This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baba, M.
Right arrow Articles by Arima, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baba, M.
Right arrow Articles by Arima, N.

 Previous Article  |  Next Article 

Journal of Virology, April 2008, p. 3843-3852, Vol. 82, No. 8
0022-538X/08/$08.00+0     doi:10.1128/JVI.02013-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Highly Enhanced Expression of CD70 on Human T-Lymphotropic Virus Type 1-Carrying T-Cell Lines and Adult T-Cell Leukemia Cells{triangledown}

Masanori Baba,1,{dagger}* Mika Okamoto,1,{dagger} Takayuki Hamasaki,1 Sawako Horai,2 Xin Wang,1,{ddagger} Yuji Ito,3 Yasuo Suda,4 and Naomichi Arima2

Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8544, Japan,1 Division of Host Response, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8544, Japan,2 Department of Bioengineering, Faculty of Engineering, Kagoshima University, Kagoshima 890-0065, Japan,3 Nanostructured and Advanced Materials Course, Graduate School of Science and Engineering, Kagoshima University, Kagoshima 890-0065, Japan4

Received 11 September 2007/ Accepted 30 January 2008

Human T-lymphotropic virus type 1 (HTLV-1) is the etiologic agent of adult T-cell leukemia (ATL). In Japan, the number of HTLV-1 carriers is estimated to be 1.2 million and more than 700 cases of ATL have been diagnosed every year. Considering the poor prognosis and lack of curative therapy of ATL, it seems mandatory to establish an effective strategy for the treatment of ATL. In this study, we attempted to identify the cell surface molecules that will become suitable targets of antibodies for anti-ATL therapy. The expression levels of approximately 40,000 host genes of three human T-cell lines carrying HTLV-1 genomes were analyzed by oligonucleotide microarray and compared with the expression levels of the genes in an HTLV-1-negative T-cell line. The HTLV-1-carrying T-cell lines used for experiments had totally different expression patterns of viral genome. Among the genes evaluated, the expression levels of 108 genes were found to be enhanced more than 10-fold in all of the T-cell lines examined and 11 of the 108 genes were considered to generate the proteins expressed on the cell surface. In particular, the CD70 gene was upregulated more than 1,000-fold and the enhanced expression of the CD70 molecule was confirmed by laser flow cytometry for various HTLV-1-carrying T-cell lines and primary CD4+ T cells isolated from acute-type ATL patients. Such expression was not observed for primary CD4+ T cells isolated from healthy donors. Since CD70 expression is strictly restricted in normal tissues, such as highly activated T and B cells, CD70 appears to be a potential target for effective antibody therapy against ATL.

* Corresponding author. Mailing address: Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1, Sakuragaoka, Kagoshima 890-8544, Japan. Phone: 81-99-275-5930. Fax: 81-99-275-5932. E-mail: m-baba{at}vanilla.ocn.ne.jp

{triangledown} Published ahead of print on 6 February 2008.

{dagger} These authors contributed equally to this work.

{ddagger} Present address: Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520.

Journal of Virology, April 2008, p. 3843-3852, Vol. 82, No. 8
0022-538X/08/$08.00+0     doi:10.1128/JVI.02013-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Muraoka, S., Ito, Y., Kamimura, M., Baba, M., Arima, N., Suda, Y., Hashiguchi, S., Torikai, M., Nakashima, T., Sugimura, K. (2009). Effective Induction of Cell Death on Adult T-Cell Leukaemia Cells by HLA-DR{beta}-Specific Small Antibody Fragment Isolated from Human Antibody Phage Library. J Biochem 145: 799-810 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»